METASTATIC OSTEOSARCOMA
Clinical trials for METASTATIC OSTEOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC OSTEOSARCOMA trials appear
Sign up with your email to follow new studies for METASTATIC OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to fight Hard-to-Treat sarcomas
Disease control OngoingThis study tests whether two immunotherapy drugs, oleclumab and durvalumab, can help people with sarcoma that has come back, spread, or stopped responding to treatment. About 75 adults and some teens (age 12+) with angiosarcoma, dedifferentiated liposarcoma, or osteosarcoma will …
Matched conditions: METASTATIC OSTEOSARCOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 11:34 UTC
-
Experimental drug shows promise for rare bone cancers
Disease control OngoingThis study tests a drug called cabozantinib in people whose osteosarcoma or Ewing sarcoma has returned or worsened after standard treatment. The drug works by blocking enzymes that help cancer cells grow and by cutting off the blood supply tumors need. The main goal is to see if …
Matched conditions: METASTATIC OSTEOSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 11:34 UTC
-
Inhaled therapy shows promise for lung metastases
Disease control OngoingThis study tests an inhaled form of a protein called interleukin-2 (IL-2) to treat cancers that have spread to the lungs, such as melanoma, kidney cancer, and sarcoma. The goal is to find the safest dose and see if it can shrink tumors. About 70 adults with advanced cancer and lu…
Matched conditions: METASTATIC OSTEOSARCOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:40 UTC